乳腺癌预防的三期临床试验：雌激素靶向药物,选择性雌激素受体调控剂和芳香酶抑制剂
Barbara K. Dunn
Phase 3 Trials in Breast Cancer Prevention：Focus on Estrogen-Targeting Agents, Selective Estrogen Receptor Modulators and Aromatase Inhibitors
Barbara K. Dunn
化学进展
.
2013, (09): 1429
-1449
.
DOI: 10.7536/PC130747
